Dongming Hou, MD, PhD

Vice President, Global Clinical Science
Genesis MedTech, United States

Dr. Hou recently joined Genesis MedTech as Vice President of Global Clinical Science. Previously, he was a Distinguished Corporate Fellow R&D at Boston Scientific. Dr. Hou completed his interventional cardiology training at Beijing Medical University and his research fellowship at Krannert Institute of Cardiology, Indiana Univ. School of Medicine. Dr. Hou has authored numerous scientific publications and holds several US patents. He also served as an abstract reviewer for several cardiovascular conferences and is a current voting member of SCAI International Committee.

Presentation(s):

• CARDIOTUBE INTERVIEW: Innovation Competition 6: Transcatheter Therapy ForPure Aortic Regurgitation: Insights From A Preclinical Animal Model

  Monday, February 27, 2023
  9:15 AM – 9:25 AM ET

  Disclosure information not submitted.

• Transcatheter Therapy for Pure Aortic Regurgitation: Insights From a Preclinical Animal Model

  Monday, February 27, 2023
  3:32 PM – 3:40 PM ET

  Disclosure(s): Genesis MedTech: Employee (Ongoing)